EUVIMEDEUVIMED entdecken
Open Access

Fetal hypoplastic lungs have multilineage inflammation that is reversed by amniotic fluid stem cell extracellular vesicle treatment

Lina Antounians iD, Rebeca Lopes Figueira, Bharti Kukreja, Michael L Litvack iD, Elke Zani-Ruttenstock iD, Kasra Khalaj iD, Louise Montalva, Fabian Doktor, Mikal Obed iD, Matisse Blundell iD, Taiyi Wu iD, Cadia Chan iD und 6 weitere

Science Advances · 2024

DOI: 10.1126/sciadv.adn5405 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2024. Verfasst von Lina Antounians und 17 weiteren Autor:innen. Beteiligte Einrichtung: Developmental and Stem Cell Biology Program, Peter Gilgan Centre for Research and Learning, The Hospital for Sick Children, Toronto M5G 0A4, Canada. Hauptthemen laut MEDLINE: Extracellular Vesicles, Amniotic Fluid, Lung. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 140 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antenatal administration of extracellular vesicles from amniotic fluid stem cells (AFSC-EVs) reverses features of pulmonary hypoplasia in models of congenital diaphragmatic hernia (CDH). However, it remains unknown which lung cellular compartments and biological pathways are affected by AFSC-EV therapy. Herein, we conducted single-nucleus RNA sequencing (snRNA-seq) on rat fetal CDH lungs treated with vehicle or AFSC-EVs. We identified that intra-amniotically injected AFSC-EVs reach the fetal lung in rats with CDH, where they promote lung branching morphogenesis and epithelial cell differentiation. Moreover, snRNA-seq revealed that rat fetal CDH lungs have a multilineage inflammatory signature with macrophage enrichment, which is reversed by AFSC-EV treatment. Macrophage enrichment in CDH fetal rat lungs was confirmed by immunofluorescence, flow cytometry, and inhibition studies with GW2580. Moreover, we validated macrophage enrichment in human fetal CDH lung autopsy samples. Together, this study advances knowledge on the pathogenesis of pulmonary hypoplasia and further evidence on the value of an EV-based therapy for CDH fetuses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracellular VesiclesAmniotic FluidLungAnimalsRatsHumansStem CellsInflammationHernias, Diaphragmatic, CongenitalFemaleMacrophagesDisease Models, AnimalCell DifferentiationFetusPregnancyStem Cell Transplantation

Autor:innen und Institutionen

  • Developmental and Stem Cell Biology Program, Peter Gilgan Centre for Research and Learning, The Hospital for Sick Children, Toronto M5G 0A4, Canada.
  • Division of General and Thoracic Surgery, The Hospital for Sick Children, Toronto M5G 1X8, Canada.
  • Neurosciences and Mental Health Program, Peter Gilgan Centre for Research and Learning, The Hospital for Sick Children, Toronto M5G 0A4, Canada.
  • Translational Medicine Program, Peter Gilgan Centre for Research and Learning, The Hospital for Sick Children, Toronto M5G 0A4, Canada.
  • Genetics and Genome Biology Program, Peter Gilgan Centre for Research and Learning, The Hospital for Sick Children, Toronto M5G 0A4, Canada.
  • Department of Molecular Genetics, University of Toronto, Toronto M5S 1A8, Canada.

ORCID-Profile: Lina Antounians, Michael L Litvack, Elke Zani-Ruttenstock, Kasra Khalaj, Mikal Obed, Matisse Blundell, Taiyi Wu, Cadia Chan, Richard Wagner, Martin Lacher, Michael D Wilson, Martin Post, Brian T Kalish, Augusto Zani

Zitieren

APA

Antounians, L., Figueira, R. L., Kukreja, B., Litvack, M. L., Zani-Ruttenstock, E., Khalaj, K., Montalva, L., Doktor, F., Obed, M., Blundell, M., Wu, T., Chan, C., Wagner, R., Lacher, M., Wilson, M. D., Post, M., Kalish, B. T., & Zani, A. (2024). Fetal hypoplastic lungs have multilineage inflammation that is reversed by amniotic fluid stem cell extracellular vesicle treatment. Science Advances. https://doi.org/10.1126/sciadv.adn5405

Vancouver

Antounians L, Figueira RL, Kukreja B, Litvack ML, Zani-Ruttenstock E, Khalaj K, et al. Fetal hypoplastic lungs have multilineage inflammation that is reversed by amniotic fluid stem cell extracellular vesicle treatment. Science Advances. 2024. doi:10.1126/sciadv.adn5405

BibTeX
@article{Antounians2024,
  author = {Antounians, Lina and Figueira, Rebeca Lopes and Kukreja, Bharti and Litvack, Michael L and Zani-Ruttenstock, Elke and Khalaj, Kasra and Montalva, Louise and Doktor, Fabian and Obed, Mikal and Blundell, Matisse and Wu, Taiyi and Chan, Cadia and Wagner, Richard and Lacher, Martin and Wilson, Michael D and Post, Martin and Kalish, Brian T and Zani, Augusto},
  title = {Fetal hypoplastic lungs have multilineage inflammation that is reversed by amniotic fluid stem cell extracellular vesicle treatment},
  journal = {Science Advances},
  year = {2024},
  doi = {10.1126/sciadv.adn5405}
}
Kostenlos starten →